Burjeel Holdings Plc · ADX:BURJEEL
Burjeel — Investor Presentation (August 2026)
50 slides from Burjeel's investor presentation, August 2026
Slide 1: Investor Presentation
Investor Presentation A Leading Super-Specialty Healthcare Provider in the GCC August 2026
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Burjeel Holdings PLC None of the Company or its subsidiaries or any of their affiliates or based on publicly available information and non-public advisors make any representation or warranty as to the fairness, information to assist you in making a p
Slide 3: Contents
Contents 03 Investment 02 Highlights Strategic Priorities 04 Recent Performance 01 At a Glance 05 Guidance 06 Appendix
Slide 4: At a Glance
01 At a Glance Leading Super-Specialty Healthcare Provider in the Gulf
Slide 5: Leading Super-Specialty Healthcare Provider in MENA
Leading Super-Specialty 87% Healthcare Provider in MENA Patient Satisfaction Score 95% Employee Our Vision Satisfaction Score To be the Gulf’s most trusted healthcare provider, delivering world-class, 60% 7.0m Independent Patient Footfall2 compassionate care through advanced Directors technology and
Slide 6: High Quality, Large-scale Portfolio of Assets Across Geographies
High Quality, Large-scale Portfolio of Assets Across Geographies Segmental revenue contribution Geographic revenue contribution Hospital Medical Centers 1% Pharmacies Physiotherapy Dubai & centers 88% 2% Other 85% Abu Dhabi, 10% Northern Emirates Hospitals Al Dhafra & Al Ain Medical 4% Oman 9% Cente
Slide 7: Business Model
1 2 Business 1 Differentiating capabilities • • Model Level I & II Trauma Center Centralised Lab Serving all • Level III Tertiary NICU • Nuclear Medicine socio-economic • Physio & Rehab Care • Department of Thalassemia groups • Intraoperative MRI • Advanced Center for Research • Da Vinci Xi robotic
Slide 8: End-to-End Complex Care
5 Expanding geographically Oncology Multi-Organ Transplant Kidney & Liver Living & Deceased Immunotherapy Palliative Care Transplants Donation ABO-Incompatible Precision Diagnostics Nuclear Medicine Pediatric Transplants Cases Medical & Radiation Robotic Transplant Surgical Oncology Oncology Transpl
Slide 9: Strategic Priorities
02 Strategic Priorities Leading Super-Specialty Healthcare Provider in the Gulf
Slide 10: Strategic Priorities
5 Expanding geographically Ramp-up of Growth Assets Operational Excellence • Maximize utilization of the young • Strengthen multi-disciplinary care asset base to drive volume and centralized operations • Position Burjeel Medical City as • Advance medical innovation, the flagship complex-care hub edu
Slide 11: Strategic Growth Pillars
5 Expanding geographically Strategic Growth Pillars Ramp-up of Growth Assets Increasing Patient Yield Operational Excellence Geographic Expansion Group Revenue Patient Yield Group EBITDA Margin New Healthcare Assets Low- Single 5.5bn Double Mid-Term Mid-Term Mid-Term ‘25 Digit CAGR Target ‘25 752 Di
Slide 12: Reiterated Strategy: Anchoring the UAE Platform, Scaling Asset-Light Growth
Reiterated Strategy: Anchoring the UAE Platform, Scaling Asset-Light Growth Across GCC & Beyond Targeted investments to expand the network while building scalable, Balanced capital allocation to capital-efficient platforms support sustainable growth UAE Expansion HealthTech Core Network Densificatio
Slide 13: Investment Highlights
03 Investment Highlights Leading Super-Specialty Healthcare Provider in the Gulf
Slide 14: Investment Highlights: Healthcare's Investment of Choice
Investment Highlights: Healthcare’s Investment of Choice 1 Leading Position 5 Expanding Geographically in a Large & Growing Healthcare Market Through High-Return & Low-CAPEX Opportunities $99bn 1.6x 21% AED 1.5bn +18 >10% GCC Healthcare GCC Healthcare Market Burjeel Holdings Private Mid-Term Revenue
Slide 15: Market Leading Position in Large, Growing, & Resilient Market
1 Market Leading Position Market Leading Position in Large, Growing, & Resilient Market 2023E Total Healthcare Expenditure in the GCC $99bn 159 GCC market size 136 $84bn UAE & Oman & KSA market size 99 109 118 1.6x 21% Burjeel Holdings’ $26bn private hospital market share in UAE & Oman the UAE (2023
Slide 16: Super-Specialty Care Offering Driving Patient Yields
52 Expanding World-classgeographically super-specialty care Super-Specialty Care Offering Driving Patient Yields Unmatched Da Vinci Xi system Momentum in Scaling Maximizing Patient Growth & Yield Innovation & Expertise Multi-Organ & Bone Marrow Transplants Liver & Kidney Transplants 86 (100% success
Slide 17: World-Class Care Beyond Borders
2 World-class super-specialty care World-Class Care Beyond Borders Seamless, End-to-End International Patient Care Model Burjeel Medical City: A Global Healthcare Platform Patient Journey A global patient referral hub Located in Abu Dhabi, BMC Pre-Travel Health Experience After Care is only a 4-6 ho
Slide 18: Osseointegration Clinic Case Study: Scaling a Differentiated Limb Restoration Platform
2 World-class super-specialty care Osseointegration Clinic Case Study: Scaling a Differentiated Limb Restoration Platform Transforming Limb Restoration Mid-Term Strategic Initiatives (2026 – 2027) 40+ Led by Dr. Munjed Al Muderis, Scale advanced limb restoration and osseointegration through Surgerie
Slide 19: Integrated Research & Education Powering Clinical Excellence
4 2 High-growth World-class super-specialty asset mix care Integrated Research & Education Powering Clinical Excellence & Talent Development Clinical Research Medical Education Clinical Workforce Strength Talent Pipeline 540+ 140+ 1,800+ Doctors Publications IRB-Approved Clinical 1,400+ Trainees Acr
Slide 20: Unique Business Model Leveraging Multiple Touchpoints
3 Well-invested multi-brand network Unique Business Model Leveraging Multiple Touchpoints CAPEX spent from inception AED 5.3bn Well-invested and a full-scale hub-and-spoke model enables the Group to capture value across the entire patient pathway through multiple touchpoints — driving revenue, brand
Slide 21: Leading Brand Portfolio Serving Entire Socioeconomic Spectrum
3 Well-invested multi-brand network Leading Brand Portfolio Serving Entire Socioeconomic Spectrum Diverse brand portfolio and network Brands creates favourable negotiating position with insurance payers Payer Mix Revenue6 Assets1 12 Hospitals2 2 Hospitals 4 Hospitals 2 Hospitals 10 Medical centers3
Slide 22: High-Growth Asset Mix with Significant Utilization Runway
4 High-growth asset mix High-Growth Asset Mix with Significant Utilization Runway Asset Maturity Split for Hospitals1 Burjeel Medical City – significant opportunity to ramp up utilization with superior patient yields 30% Growth — high FY 2025 Mature Burjeel Hospital, Abu Dhabi Growth Burjeel Medical
Slide 23: Differentiated Growth Strategy Driving Specialized Care Across Network
5 Expanding geographically Differentiated Growth Strategy Driving Specialized Care Across Network Large, Growing, & Resilient Addressable Market Anchor Burjeel as the regional O&M leader, delivering specialist support and operational excellence across the GCC and Africa. $99bn 21% GCC market size Bu
Slide 24: +18 New Healthcare Assets: Disciplined Execution Across Growth Pipeline
55 Expanding Expandinggeographically geographically Expanding Reach, Enhancing Care: Disciplined Execution Across Growth Pipeline 2026 Expected Impact 2027- 2028 at Maturity 1 1 1 1 AED 1.5 bn Revenue Hospital Fertility Clinic Hospital Fertility Clinic Mid-20s 1 3 1 3 EBITDA Margin Day Surgery Medic
Slide 25: Operonix: Scaling Asset-Light Growth Through Strategic O&M Partnerships
5 Expanding geographically Operonix: Scaling Asset-Light Growth Through Strategic O&M Partnerships Approach Scope of Services 15% Contribution to FY’25 Partnering with Hospital O&M ER/Critical Care O&M 365k+ Net Profit Ministries of Health, Comprehensive hospital 24/7 Emergency and ICU Annual Patien
Slide 26: Digital & AI Platform: Driving Structural Efficiency, Margin Expansion
6 Accelerating digitization Digital & AI Platform: Driving Structural Efficiency, Margin Expansion & Care Excellence Digital Core Infrastructure • Unified EMR Embedded AI Across the Care Continuum • Real-time KPIs • Standardized workflows Oracle Command Center IP/OP AI & Clinical Intelligence AI-dri
Slide 27: Cash-Generative Business Model Enabling Consistent Shareholder Return
7 Cash-generative business model Cash-Generative Business Model Enabling Consistent Shareholder Return Financial performance underpinned Robust margin expansion drivers by operational excellence Healthy payer-mix with proportion Significant capacity to ramp-up of Thiqa patients increasing high growt
Slide 28: Management
8 Commitment to ESG 19.7 Strong Leadership with Well-Established Low Risk As of June 2025 Market-Oriented Corporate Governance Highly experienced leadership with focus on growing shareholder value Strong governance framework BoD of 7 Members Committees: A N B A N G A G A Audit 60% Board Independence
Slide 29: Strategic Pillars – ESG Framework
8 Commitment to ESG 19.7 Strategic Pillars – ESG Framework Low Risk As of June 2025 System Community Governance Environment Diversity Equity & Inclusion Community Engagement Corporate Governance GHG Emissions & Carbon Neutrality 1 Increase the representation of women in 1 To touch >7 million lives p
Slide 30: FY 2025 ESG Highlights
8 Commitment to ESG 19.7 FY 2025 ESG Highlights Low Risk As of June 2025 System Community Governance Environment 95% 87% Zero +2% Employee Inpatient Data breaches, corruption or Electricity satisfaction score satisfaction score bribery and whistleblowing cases Consumption 57% 100% 4 of 7 -10% Women
Slide 31: Recent Performance
04 Recent Performance Leading Super-Specialty Healthcare Provider in the Gulf
Slide 32: H1'26 Results: Resilient Growth. Emerging Stronger.
5 Expanding geographically H1’26 Results: Resilient Growth. Emerging Stronger. Key Highlights Defensive & Resilient Healthcare Platform Revenue AED 2,794m +4.4% YoY EBITDA (ex-one-offs) Operational Insured Proven Strong Financial AED 517m Continuity Demand Resilience Position +24.6% YoY Net profit (
Slide 33: Accelerating Patient Volume Growth with Expanding Market Presence
Accelerating Patient Volume Growth with Expanding Market Presence Group Outpatient Footfall, k Group Inpatient Footfall, k % OP utilization • Total patient volumes increased 9.9% YoY to % bed occupancy • Inpatient footfall rose 8.4% in Q2’26 and over 3.7 million in H1'26, with growth 7.2% in H1’26,
Slide 34: Delivered Strong Underlying Performance Despite Challenging Market Headwinds
Delivered Strong Underlying Performance Despite Challenging Market Headwinds Group Revenue, AED m Group EBITDA, AED m YoY • Q2’26 Group Revenue increased 3.7% YoY, EBITDA margin (ex-one-offs) YoY • Q2’26 Group EBITDA ex-one-offs2 rose while patient visits accelerated to 12.4% 35.0% YoY, with the mar
Slide 35: Margin Normalization Progressing Through Asset Maturity & Cost Discipline
Margin Normalization Progressing Through Asset Maturity & Cost Discipline Group OPEX Breakdown, % of Revenue Group EBITDA Analysis, AED m % EBITDA margin 83.4% 84.7% 81.3% 21.8% 16.7% 21.7% 20.0% 78.2% +85 8.7% 11.3% 11.3% 12.1% 3.9% 3.5% (17) +7 (41) 3.4% +53 26.8% 3.3% 25.2% 20.0% 306 (72) (4) 316
Slide 36: Strong Free Cash Flow Generation Along With Disciplined Capital Deployment
Strong Free Cash Flow Generation Along With Disciplined Capital Deployment Net Cash from Operating Activities, AED m Net Cash Used In Investing Activities, AED m % FCF conversion1 Growth CAPEX Maintenance CAPEX Net acquisitions and investments in associates 53% 72% 297 129 53 +67 +2 (8) 405 +96 +19
Slide 37: Well-Capitalized Balance Sheet Enhanced by Successful Debt Refinancing
Well-Capitalized Balance Sheet Enhanced by Successful Debt Refinancing AED m 30 June 2026 31 December 2025 Debt Maturity as of 31 July 2026 Bank balances and cash 224 277 1,837 Interest-bearing loans and borrowings 1,877 1,918 Bank overdraft — — Bank debt1 78 1,877 1,918 Net debt 1,653 1,641 2026 20
Slide 38: Guidance
05 Guidance Leading Super-Specialty Healthcare Provider in the Gulf
Slide 39: Mid-Term Outlook & Guidance
Mid-Term Outlook & Guidance Network Expansion Profitability 18 Healthcare Assets: 2 Hospitals — Dubai, 4 Day Surgery Centers — Group EBITDA margin expected to expand to the low-20s UAE, 6 Medical Centers — UAE, 2 Fertility Clinics — Al Ain and range on a blended basis, driven by asset ramp-up, scale
Slide 40: Appendix
06 Appendix Leading Super-Specialty Healthcare Provider in the Gulf
Slide 41: A Proven Track Record of Scale and Leadership
A Proven Track Record of Scale and Leadership 2007-2010 2015 2017 2019 2021 2023 2025 First Hospital opened Medeor Brand New unique facility focused on minimal Launched New Clinical Research Launched The Paley Middle East Launched Al Muderis in 2007 under LLH Launch invasive surgeries and alternativ
Slide 42: Transforming Cancer Care: The UAE's Leading National Network
5 Expanding geographically Transforming Cancer Care: The UAE’s Leading National Network Burjeel Cancer Institute Diversified Referral Pathways Clinical Governance (Burjeel Medical City) Strengthening Oncology Access & Research Hub for high-end specialized oncology treatments Pathology, AI & Molecula
Slide 43: Trust Fertility Center: Powering UAE's Fertility Strategy
Trust Fertility Center: Powering UAE’s Fertility Strategy with Rapid Ramp-Up Integral in Burjeel’s AED 58m 3,000+ 1,900+ ~50% Women’s Health Platform 2025 Total Unique Patient IVF, FET, & IUI Clinical Pregnancy Rate Revenue Volumes Cycles Initiated (above global average) Operational Since Dec 2024 A
Slide 44: GCC Healthcare Market Growth Drivers
GCC Healthcare Market Growth Drivers Under-penetration of healthcare expenditure 1 Strong economic growth 2 3 Favorable demographic trends vs developed countries CAGR ‘23-31E of GDP1 Healthcare expenditure as % of GDP2 +5% +3% +3% 5% 11% 17% +2% CAGR ‘24-29E +32% CAGR ‘24-29E UAE Oman KSA GCC UK USA
Slide 45: H1'26 Income Statement
H1’26 Income Statement Group Income Statement Summary Financial Performance by Segment AED m Q2’26 Q2’25 H1’26 H1’25 AED m Q2’26 Q2’25 H1’26 H1’25 Revenue 1,455 1,403 2,794 2,677 Revenue 1,455 1,403 2,794 2,677 Inventories consumed (290) (375) (559) (674) Hospitals4 1,312 1,245 2,501 2,371 Doctors’
Slide 46: FY'25 Income Statement
FY’25 Income Statement Group Income Statement Summary Financial Performance by Segment AED m FY’25 FY’24 AED m FY’25 FY’24 Revenue 5,486 5,010 Revenue 5,486 5,010 Inventories consumed (1,261) (1,246) Hospitals2 4,840 4,521 Medical Centers2 468 374 Doctors’ and other employees’ salaries (2,403) (2,18
Slide 47: H1'26 & FY'25 Balance Sheet
H1’26 & FY’25 Balance Sheet Balance Sheet Summary AED m 30 June 2026 31 Dec 2025 AED m 30 June 2026 31 Dec 2025 Shareholders' equity Non-current assets Share capital 521 521 Property and equipment 2,081 2,133 Shareholder’s contribution 4 4 Intangible assets 17 20 Other reserves 3 3 Right-of-use asse
Slide 48: H1'26 Cash Flow Statement
H1’26 Cash Flow Statement Cash Flow Summary AED, m H1’26 H1‘25 Operating activities Net Profit for the Period Before Tax 227 208 Non-cash movements 419 323 Working capital movements (175) (242) Other (66) (60) Net Cash, Operating activities 405 229 Investing activities CAPEX (property, equipment, CW
Slide 49: FY'25 Cash Flow Statement
FY’25 Cash Flow Statement Cash Flow Summary AED, m FY’25 FY’24 Operating activities Net Profit for the Period Before Tax 541 399 Non-cash adjustments 711 630 Working capital adjustments (677) (415) Other (173) (114) Net Cash, Operating activities 402 500 Investing activities CAPEX (property, equipme
Slide 50: IR Contacts
IR Contacts August 2026 Sergei Levitskii Director of Investor Relations Investor Feedback Hotline sergei.levitskii@burjeelholdings.com T: +971 2 3041 111 Engaging openly with our investors and analysts is a cornerstone of our approach. We’ve partnered with Closir to make sharing your feedback quick
Burjeel Holdings — Investor Presentation (August 2026) on 6ix